Application of the GheOP³S-tool in nursing home residents: acceptance and implementation of pharmacist recommendations

References

• (OECD).Health at a Glance 2017: Oecd indicators. OECD Publishing. Paris. [cited 2018 Nov 11]. Available from: doi: 10.1787/health_glance-2017-en
   Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995.
   Google Scholar
• Masnoon, N., Shakib S, Kalisch-Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.
   Google Scholar
• Kaufmann CP, Stampfli D, Hersberger KE, et al. Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ Open. 2015;5(3):e006376-e006376.
   Google Scholar
• Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173–184.
   Google Scholar
• Lund BC, Carnahan RM, Egge JA, et al. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother. 2010;44(6):957–963.
   Google Scholar
• Patel NS, Patel TK, Patel PB, et al. Hospitalizations due to preventable adverse reactions—a systematic review. Eur J Clin Pharmacol. 2017;73(4):385–398.
   Google Scholar
• Do Nascimento MMG, Mambrini JVDM, Lima-Costa MF, et al. Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults. Eur J Clin Pharmacol. 2017;73(5):615–621.
   Google Scholar
• Alldred DP, Kennedy M-C, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016 2.
   Google Scholar
• Anrys PMS, Strauven GC, Foulon V, et al. Potentially inappropriate prescribing in Belgian nursing homes: prevalence and associated factors. J Am Med Dir Assoc. 2018;19(10):884–890.
   Google Scholar
• Jokanovic N, Tan EC, Sudhakaran S, et al. Pharmacist-led medication review in community settings: an overview of systematic reviews. Res Social Adm Pharm. 2017;13(4):661–685.
   Google Scholar
• Panel AGS. American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2015;63(11):2227–2246.
   Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–218.
   Google Scholar
• Tommelein E, Petrovic M, Somers A, et al. Older patients’ prescriptions screening in the community pharmacy: development of the Ghent older people’s prescriptions community pharmacy screening (GheOP(3)S) tool. J Public Health (Oxf). 2016;38(2):e158–70.
   Google Scholar
• Kympers C., et al. Detection of potentially inappropriate prescribing in older patients with the gheop(3)s-tool: completeness and clinical relevance. Acta Clinica Belgica. 2019;74(2):126–136.
   Google Scholar
• Kwint HF, Bermingham L, Faber A, et al. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91–102.
   Google Scholar
• Denneboom W, Dautzenberg MGH, Grol R, et al. Treatment reviews of older people on polypharmacy in primary care: cluster controlled trial comparing two approaches. Br J Gen Pract. 2007;57(542):723–731.
   Google Scholar
• Tommelein E, Mehuys E, Petrovic M, et al. Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP3S-tool. Int J Clin Pharm. 2016;38:1063–1068.
   Google Scholar
• Pharmaceutical Care network Europe (PCNE). Position paper on the PCNE definition of medication review 2016. [cited 2018 Jun 5]. Available from: http://www.pcne.org/upload/files/149_Position_Paper_on_PCNE_Medication_Review_final.pdf
   Google Scholar
• Kanis JA, McCloskey EV, Johansson H, et al. Development and use of FRAX in osteoporosis. Osteoporos Int. 2010;21 Suppl 2:S407–13.
   Google Scholar
• Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007;167(8):781–787.
   Google Scholar
• Wilson NM, March LM, Sambrook PN, et al. Medication safety in residential aged-care facilities: a perspective. Ther Adv Drug Saf. 2010;1(1):11–20.
   Google Scholar
• Cardwell K, Hughes CM, Ryan C. The association between anticholinergic medication burden and health related outcomes in the ‘oldest old’: a systematic review of the literature. Drugs Aging. 2015;32(10):835–848.
   Google Scholar
• Wouters H, van der Meer H, Taxis K. Quantification of anticholinergic and sedative drug load with the drug burden index: a review of outcomes and methodological quality of studies. Eur J Clin Pharmacol. 2017;73(3):257–266.
   Google Scholar
• Belgisch Centrum voor Farmacotherapeutische Informatie (BCFI). Belgian commented drugs repertory http://www.bcfi.be/; 2017 [cited 2017 Jun 10]. Available from: http://www.bcfi.be/
   Google Scholar
• Duran CE, Azermai M, Vander Stichele RH. Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol. 2013;69(7):1485–1496.
   Google Scholar
• Morin L, Laroche M-L, Texier G, et al. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862.e1-9.
   Google Scholar
• King MA, Roberts MS. Multidisciplinary case conference reviews: improving outcomes for nursing home residents, carers and health professionals. Pharm World Sci. 2001;23(2):41–45.
   Google Scholar
• Furniss L, Burns A, Craig SK, et al. Effects of a pharmacist’s medication review in nursing homes. Randomised controlled trial. Br J Psychiatry. 2000;176:563–567.
   Google Scholar
• Verrue C, Mehuys E, Boussery K, et al. A pharmacist-conducted medication review in nursing home residents: impact on the appropriateness of prescribing. Acta Clin Belg. 2012;67(6):423–429.
   Google Scholar
• Frankenthal D, Lerman Y, Kalendaryev E, et al. Intervention with the screening tool of older persons potentially inappropriate prescriptions/screening tool to alert doctors to right treatment criteria in elderly residents of a chronic geriatric facility: a randomized clinical trial. J Am Geriatr Soc. 2014;62(9):1658–1665.
   Google Scholar
• Reeve E, To J, Hendrix I, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.
   Google Scholar
• Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.
   Google Scholar
• Harrison SL, Kouladjian O’Donnell L, Bradley CE, et al. Associations between the drug burden index, potentially inappropriate medications and quality of life in residential aged care. Drugs Aging. 2018;35(1):83–91.
   Google Scholar
• Kouladjian L, Gnjidic D, Chen TF, et al. Drug burden index in older adults: theoretical and practical issues. Clin Interv Aging. 2014;9:1503–1515.
   Google Scholar
• Bourgeois J, Elseviers MM, Van Bortel L, et al. Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study. Eur J Clin Pharmacol. 2014;70(10):1251–1260.
   Google Scholar
• Gurwitz JH, Bonner A, Berwick DM. Reducing excessive use of antipsychotic agents in nursing homes. JAMA. 2017;318(2):118–119.
   Google Scholar
• Azermai M, Wauters M, De Meester D, et al. A quality improvement initiative on the use of psychotropic drugs in nursing homes in Flanders. Acta Clin Belg. 2017;72(3):163–171.
   Google Scholar
• Jansen, J., Naganathan V, Carter SM, et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353:i2893.
   Google Scholar
• Loganathan M, Singh S, Franklin BD, et al. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40(2):150–162.
   Google Scholar
• Crome P, Cherubini A, Oristrell J. The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond. Expert Rev Clin Pharmacol. 2014;7(4):457–468.
   Google Scholar
• Carandang L, Goldsack JC, Sonnad SS. Key issues for elderly patients contemplating clinical trial participation. J Women Aging. 2016;28(5):412–417.
   Google Scholar
• Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33(3):549–557.
   Google Scholar
• Holmes HM, Sachs GA. Meaningful deprescribing in the nursing home. Ann Intern Med. 2017;167:671.
   Google Scholar
• Wouters H, Scheper J, Koning H, et al. Discontinuing inappropriate medication use in nursing home residents: A cluster randomized controlled trial. Ann Intern Med. 2017;167:609.
   Google Scholar